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A number of laboratories, including
our own, are attempting to dissect
the neural mechanisms that support
and mediate interactions between
conscious perception, interoceptive
control, and emotional feelings. In par-
allel, studies of the functional neurobi-
ology of the cognitive control of anxi-
ety and the facilitation of motivational
‘‘unlearning’’ and extinction highlight
the importance of affective neurosci-
ence to clinical therapeutics. In the
study by Naqvi and coworkers, the
effects of insula lesions on smoking
addiction are reminiscent of an
‘‘interoceptive agnosia’’ arising from
disruption of viscerosensory represen-
tations (Nauta, 1971; Damasio, 1994).
Their study identifies a crucial neural
substrate for craving and emphasizes
the critical role of conscious feeling
states in driving habitual behavior. Un-
derpinning this role of insula cortex in
craving is its status as viscerosensory
cortex and as the neural substrate for
interoceptive feeling states.
Why did not all smokers with insula
lesions quit? Obviously a number of
factors play a role in the maintenance
of addiction, only some of which are
usefully explained at the neural level.
Of these, alterations in striatal dopami-
nergic reward-related processing are
well recognized to play a critical role.
The degree to which reward/goal-
selection processes and interoceptive
awareness of craving differentially
contribute to drug-seeking behavior
is not known. One important next
step in further understanding the inter-
play between the multiple neural sys-
tems mediating addiction (Hyman
et al., 2006) would be to dissociate
striatal dopaminergic error-prediction
signals (Pessiglione et al., 2006) from
linear associations between subjective
craving and right anterior insula activ-
ity within addicted patients.
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A critical molecular requirement underlying many forms of long-lasting synaptic plasticity and mem-
ory is the de novo synthesis of mRNAs and proteins. In a recent paper in Cell, Costa-Mattioli et al.
present data from a pharmacogenetic study that places a key regulatory event in the ‘‘neural deci-
sion’’ to undergo these persistent neuronal changes under translational control mediated by eIF2a.An old adage states that ‘‘a moment
lasts all of a second, but the memory
lives on forever.’’ The molecular mech-
anisms that regulate the ‘‘forever’’ or
long-term aspects of memory forma-
tion have been the subject of intense
study for over three decades in more186 Neuron 54, April 19, 2007 ª2007 Elsthan a dozen model organism sys-
tems. Although the temporal bound-
aries that define long-term memory
(LTM) vary significantly between mol-
lusks, insects, and vertebrates, in all
cases examined thus far, the synthesis
of new mRNAs and proteins gates theevier Inc.transition between short-term memory
(STM) and LTM (Klann and Dever,
2004). These new proteins are be-
lieved to produce and maintain long-
lasting neuronal changes (most likely
at the synapse), which are manifested
behaviorally as memory. The Holy
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a certain extent, industry nootropic
‘‘smart drug’’ efforts) has been the
identification of the critical regulator(s),
or the ‘‘master,’’ molecular switch that
controls the transition between short-
term and long-term plastic change.
The first molecule identified that fits
the definition of master molecular
switch was cAMP element-binding
protein (CREB). In simplistic terms,
CREB is a transcription factor that pro-
motes the transcription of several
downstream gene targets that in turn
regulate long-term plasticity. Many
studies support the idea that CREB is
a critical switch regulating the thresh-
old to enduring neuronal changes.
Overexpression of CREB activator iso-
forms, inhibition of CREB repressor
isoforms, or expression of activated
CREB constructs enhances synaptic
plasticity and LTM in both vertebrate
and invertebrate systems (Carlezon
et al., 2005). However, recent studies
have identified other potential tran-
scriptional master switches, such as
AP1 and c-rel, that have also been im-
plicated in synaptic plasticity and LTM
(Levenson et al., 2004; Sanyal et al.,
2002). Regardless, a common theme
that emerges is that the master switch
in transducing STM to LTM lies
squarely within the dominion of tran-
scriptional control. But what about
translation, transcription’s partner in
cellular physiology? Is translation
merely an inevitable outcome of
mRNA synthesis?
The importance of translation in LTM
has been known for at least as long as
transcription (Squire and Barondes,
1973). But strangely enough, the idea
that the translational machinery may
act as a specific target of regulation
during long-lasting plastic processes
has only become evident more re-
cently. A key experiment highlighting
the critical and separate role of transla-
tion in long-term plasticity showed that
long-term potentiation (LTP) induced
by the neurotrophic factor BDNF re-
mained protein synthesis dependent
and persisted at dendrites that had
been separated from their cell bodies
(Kang and Schuman, 1996). More re-
cent studies have highlighted the es-
sential role of the translation initiationmachinery in plasticity (Banko et al.,
2005; Govindarajan et al., 2006; Kel-
leher et al., 2004; Klann and Dever,
2004). However, what has yet to be
shown is how translation can gate the
transition of STM to LTM. Costa-
Mattioli and colleagues (Costa-Mattioli
et al., 2007) make a compelling case
for the identification of just such
a translational ‘‘master’’ switch.
‘‘With the brain, you know you’ve
got something when you have hold of
a molecule in one hand and can feel
the tug on behavior with the other.’’
This quote (from an unnamed neuro-
scientist) has been the guiding princi-
ple of many genetic disruption studies
aimed at examining learning and mem-
ory. Genes are knocked out and then
effects on plasticity and memory are
assessed. Costa-Mattioli et al. exam-
ined long-lasting plasticity in heterozy-
gous mutant mice lacking a serine
(S51A) phosphorylation site on eIF2a
(Costa-Mattioli et al., 2007). eIF2a is
a component of the translation initia-
tion complex that when phosphory-
lated at S51 acts to repress general
translation. Importantly, although
eIF2a phosphorylation reduces gen-
eral translation, the translation of
some specific mRNA is enhanced
rather than repressed. One mRNA
regulated in this fashion is activating
transcription factor-4 (ATF4) (Harding
et al., 2000). ATF4 functions as a
transcriptional antagonist of CRE-
mediated gene expression, opposing
the activity of the activated CREB.
In eIF2aS51A/+ mice, Costa-Mattioli
et al. report that ATF4 levels are de-
creased. Interestingly, they find that
the threshold for inducing long-lasting,
protein synthesis-dependent late-
phase LTP (L-LTP) is reduced without
altering the manifestation of LTP,
suggesting that the function of eIF2a
is to regulate the induction of L-LTP
rather than the expression or mainte-
nance of L-LTP. Enhanced L-LTP has
been demonstrated in other mouse
mutants, and rather than improved
memory, it is often correlated with
learning and memory deficits (Banko
et al., 2005; Gu et al., 2002). What
makes the eIF2aS51A/+ mouse intrigu-
ing is that the enhanced L-LTP is cor-
related with enhanced memory in sev-Neuron 54eral tasks, including the Morris water
maze (MWM), associative conditioned
fear, and conditioned taste aversion
(CTA). Moreover, it appears that the
threshold for the acquisition of long-
lasting memory in these paradigms
has been reduced, as the mice acquire
the MWM platform location with fewer
trials, exhibit increased freezing to
weaker stimuli during fear condition-
ing, and have faster extinction rates
in the latent inhibition version of CTA.
In parallel to their LTP findings, the au-
thors found that the overall magnitude
of memory in these mice was es-
sentially unchanged. In the MWM,
learning rates were increased, and
in CTA and conditioned fear, LTM
was formed when it would not have
been otherwise. These findings
strengthen the idea that eIF2a phos-
phorylation functions to gate long-
term neuronal changes rather than
alter their expression.
Switching strategies, Costa-Mattioli
et al. next utilized a pharmacological
approach to examine the role of
increased eIF2a phosphorylation on
long-lasting plasticity. They accom-
plished this using the drug Sal003, an
agent that blocks the activity of eIF2a
phosphatases (Boyce et al., 2005).
Using this drug, the authors found
that L-LTP was blocked in wild-type
slices. In an interesting experiment,
they also examine the effects of
Sal003 treatment on translation by
examining actively translating poly-
somes. Examining Sal003-treated
embryonic fibroblasts, the authors
found ATF4 mRNA shifted to actively
translating polysome fractions,
whereas b-actin mRNA shifted to
lower-density fractions. The impact of
this experiment would have been
more profound if the polysomes were
purified from either synaptoneuro-
somes or cultured hippocampal prep-
arations, but given the quantity of
starting material required for this
sort of preparation, the authors’
compromise is a fair one. Further
strengthening their argument, they
proceed to demonstrate that not
only is dephosphorylation of eIF2a
a normal consequence of fear lear-
ning, but that Sal003 can impair
LTM., April 19, 2007 ª2007 Elsevier Inc. 187
Neuron
PreviewsFigure 1. Translational Control Mechanisms that Regulate Gene Expression
(A) Transcriptional control via ATF4 resulting from genome-wide inhibition of CRE-dependent gene
expression. Expression of ATF4 is regulated by the phosphorylation state of eIF2a. When eIF2a is
phosphorylated, general translation is reduced but ATF4 translation is enhanced, which reduces
CRE-dependent gene expression. When eIF2a is dephosphorylated, ATF4 inhibition is relieved
(described by Costa-Mattioli et al., 2007).
(B) Transcriptional control of gene expression by rapid synthesis of transcription factor (i.e.,
CREB). Transcription factor availability controls gene expression either via levels or via transport
to the nucleus.
(C) Regulation of gene expression via mRNA transcript sequestration and transport. RNA-binding
proteins (such as FMRP) can bind and prevent mRNA from being translated to protein, thereby
blocking gene expression. Proteasome regulatory factors, which could result in either degradation
or transport of RNA-binding proteins, could also regulate translation to control gene expression.The most convincing and elegant
experiment performed by Costa-
Mattioli and colleagues is one utilizing
a powerful pharmacogenetic ap-
proach. In this experiment, the authors
demonstrate that the inhibition of
L-LTP by Sal003 is mediated entirely
by ATF4. The authors accomplish this
by determining that L-LTP in hippo-
campal slices from ATF4 knockout
mice is completely resistant to Sal003
treatment. In other words, the conse-
quences of increased eIF2a phosphor-
ylation, at least with respect to L-LTP,
are principally funneled through a sin-
gle transcription factor, ATF4. In this
way, translation rather than transcrip-
tion acts as the master molecular
switch controlling the transition
between short-term and long-term
plasticity.
The findings of Costa-Mattioli and
colleagues highlight a critical relation-
ship between neuronal translation
and transcription (Figure 1). Transla-188 Neuron 54, April 19, 2007 ª2007 Elstion of immediate-early gene products,
which in turn feed forward to drive
gene expression, has been demon-
strated recently (Wagatsuma et al.,
2006). Fragile X mental retardation
protein (FMRP) is an RNA-binding pro-
tein that acts as a translational repres-
sor by binding numerous G-quartet-
containing mRNAs regulating their
accessibility or transport. Levels of
FMRP are dynamically regulated by
synaptic activity and therefore can
viewed as ‘‘upstream’’ of transcription
by controlling gene expression (Hou
et al., 2006). Other mechanisms influ-
enced by translation that can affect
transcription, such as local synthesis
of proteosome regulators, which could
either degrade transcriptional repres-
sors or induce micro-RNA production,
may be other routes through which
translation acts to regulate transcrip-
tion.
Costa-Mattioli et al. demonstrate
the critical role of a single phosphory-evier Inc.lation site on the translation factor
eIF2a in regulating long-lasting synap-
tic change. Moreover, it moves the
crucial ‘‘switch’’ event for memory
out of the nucleus into the realm of
translation by placing phosphorylation
of eIF2a upstream of ATF4, a repressor
of CREB-mediated transcription. So,
is the search for the master switch for
memory over? If history is any indica-
tor, then likely not, as memory ‘‘mas-
ter’’ control molecules have been
piling up (CaMKII, PKMz, ERK, Fos,
C/EBP, and CREB, to name just
a few). In addition, important questions
remain with respect to eIF2a and its
role in long-lasting plasticity and mem-
ory: what other mRNAs are upregu-
lated when there is increased eIF2a
phosphorylation? How are the kinase
and phosphatase activities that modu-
late eIF2a phosphorylation regulated?
Can memory deficits induced by
Sal003 also be rescued via deletion
of ATF4? The effective development
of microarray technology more than
a decade ago led numerous labs to en-
gage in screens to identify pools of
gene products under the control of
specific promoter elements like CRE.
The actual number of genes isolated
from such work is quite small, which
begs the following question: is there
really a single (or small number) of mol-
ecules that control long-lasting plas-
ticity and/or long-term memory? Stud-
ies like the one by Costa-Mattioli et al.
argue that this may be the case, but
the term ‘‘master’’ may be aptly re-
placed with ‘‘strongly influential.’’
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